|
**Overview**: Hepatitis B Profile Panel**Introduction**: The Hepatitis B Profile Panel is a diagnostic tool designed for comprehensive hepatitis B screening using serum samples. In India, HBV chronic infection affects ~40 million (~3 percent), with full serologic profile (HBsAg, HBsAb, HBcAb total/IgM, HBeAg, HBeAb) essential for determining acute/chronic status, infectivity, and immunity. High morbidity from under-testing in rural/low-SES populations with jaundice or risk factors, limited labs, delayed antiviral therapy leading to cirrhosis or HCC. Per microbiology/immunology practices aligned with ICMR and National Viral Hepatitis Control Programme guidelines, the test employs immunoassay for 6 markers over 1-2 days with high accuracy, valuable for complete HBV status assessment. This diagnostic falls under viral screening and targets patients with liver symptoms, high-risk exposure, or pre-immunosuppression, addressing accurate detection to guide antiviral therapy or monitoring. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise staging and reducing HBV complications. Its serum-based approach ensures reliable serology.**Other Names**: Hep B Profile Pnl.**FDA Status**: FDA approved, CLIA certified for immunology/microbiology, compliant with 2025 standards.**Historical Milestone**: Full HBV profile standard; in India, key in hepatitis control.**Purpose**: The test assesses 6 parameters including HBsAg to guide comprehensive hepatitis B screening, determine status/infectivity, inform therapy.**Test Parameters**: 1. HBsAg, 2. HBsAb, 3. HBcAb Total, 4. HBcAb IgM, 5. HBeAg, 6. HBeAb.**Pretest Condition**: No fasting required; patients should report jaundice or risk factors.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptoms, vaccination, exposure risk.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected HBV including cirrhosis, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or window period can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Marker pattern determines acute/chronic/inactive carrier status, necessitating specialist input.**Specialist Consultation**: Hepatologists should be consulted for management.**Additional Supporting Tests**: HBV DNA, liver function tests for confirmation.**Test Limitations**: Does not assess viral load; comprehensive approach required.**References**: Indian Journal of Medical Microbiology 2024, HBV Studies India 2023. |
